
Cross-section of a retinal organoid, showing hybrid cells (green) engrafting onto the tissue. Red fluorescence indicates the activity of new ganglions being formed.
Credit: Sergi Bonilla/Lancet eBioMedicine
Fusing human retinal cells with adult stem cells could be a potential therapeutic strategy to treat retinal damage and visual impairment, according to the findings of a new study published in the journal eBioMedicine. The hybrid cells act by awakening the regenerative potential of human retinal tissue, previously only thought to be the preserve of cold-blood vertebrates.
Cell fusion events – the combination of two different cells into one single entity – are known to be a possible mechanism contributing to tissue regeneration. Though rare in humans, the phenomenon has been consistently detected in the liver, brain, and gastrointestinal tract.
A team led by ICREA Research Professor Pia Cosma at the Centre for Genomic Regulation (CRG) in Barcelona and funded by Fundació “la Caixa” has now found that cell fusion events also take place in the human retina.
The researchers tested whether cell fusion events could differentiate into cells that turn into neurons, which would show potential for tissue regeneration. The team fused Müller glia, cells that play a secondary but important role in maintaining the structure and function of the retina, with adult stem cells derived from human adipose tissue or bone marrow.
“We were able to carry out cell fusion in vitro, creating hybrid cells. Importantly, the process was more efficient in the presence of a chemical signal transmitted from the retina in response to damage, resulting in rates of hybridisation increasing twofold. This gave us an important clue for the role of cell fusion in the retina,” says Sergi Bonilla, postdoctoral researcher at the CRG at the time of publication and first author of the study.
The hybrid cells were injected into a growing retinal organoid, a model that closely resembles the function of the human retina. The researchers found that the hybrid cells successfully engrafted into the tissue and differentiated into cells that closely resemble ganglion cells, a type of neuron essential for vision.
“Our findings are important because they show that the Müller Glia in the human retina have the potential to regenerate neurons,” says Pia Cosma. “Salamanders and fish can repair damage caused to the retina thanks to their Müller glia, which differentiate into neurons that rescue or replace damaged neurons. Mammalian Müller glia have lost this regenerative capacity, which means retinal damage or degradation can lead to visual impairment for life. Our findings bring us one step closer to recovering this ability.”
The authors caution that much work remains to be done before the development of any potential treatments. One of the next steps is understanding why hybrid cells – with four complete sets of chromosomes – don’t result in chromosomal instability and cancer development. The authors of the study believe the retina may have a mechanism regulating chromosome segregation similar to the liver, which contains tetraploid cells that act as a genetic reservoir, undergoing mitosis in response to stress and injury.
Original Article: Cell fusion ‘awakens’ regenerative potential of human retina
More from: Centre for Genomic Regulation | Institute for Bioengineering of Catalonia
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell fusion
- Biosion bispecific antibody therapies to be featured at the American Association for Cancer Research (AACR) annual meeting 2023
Biosion bispecific antibody therapies to be featured at the American Association for Cancer Research (AACR) annual meeting 2023 Mar 22, 2023 (PRNewswire ...
- New SARS-CoV-2 target could boost immunity against all coronaviruses
Researchers searching for new therapeutic targets in the SARS-CoV-2 virus have identified a potential Achilles' heel that exists in all coronaviruses, according to a study published today in eLife.
- Acute leukemia: 30% of participants achieve remission with new drug
A treatment called revumenib, which inhibits the protein menin, showed promising results for individuals with acute leukemia, and aided remission in 30% of study participants.
- Emerging tech, explained
Attention to emerging technology also impacts the U.S. economy–the country where the platforms are created is where many of the jobs will be. Some key technologies that will be battlegrounds for the ...
- BioNTech Puts Up $200M to Partner With OncoC4 in Cancer Immunotherapy
BioNTech is expanding its cancer immunotherapy scope by partnering with OncoC4 on clinical testing of its lead drug. The antibody was designed to offer a safety edge over other CTLA-4-blocking drugs ...
Go deeper with Google Headlines on:
Cell fusion
[google_news title=”” keyword=”cell fusion” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Retina regeneration
- Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress
(“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today provided an update on its ...
- Sighthill bridge: A Glasgow regeneration that will make a difference
The Sighthill Bridge over the M8 is the centrepiece of a £250m regeneration of the area which really must be visited over several days to be appreciated. It’s the grandest project of its kind ...
- How transport infrastructure can unlock regeneration and levelling up
Recent Levelling Up Fund (LUF) awards highlight how transport priorities are a critical part of the regeneration agenda. Even as the LUF was over-subscribed by three to four times, ambitious transport ...
- Retinal Vein Occlusion Treatment Market is expected to garner a value of US$ 4.7 billion by 2033
The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a valuation of US$ 2.3 billion is expected for the ...
- I Tried Peach & Lily’s Retinal for All Renewing Serum — Here's What I Thought
Those with sensitive skin might shy away from potent retinoid products, but Korean skincare brand Peach & Lily has created a retinal “for all" that prevents irritation and actually soothes skin.
Go deeper with Google Headlines on:
Retina regeneration
[google_news title=”” keyword=”retina regeneration” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]